Local/regional recombinant interleukin 2 (rIL-2) immunotherapy of tumors. Intra-arterial continuous infusion of rIL-2 in bladder cancer patients: a phase I study.

Velotti, F; Tubaro, A; Stoppacciaro, A; Pettinato, A; Morrone, S; Bossola, P; Napolitano, T; Miano, L; Ruco, L; Piccoli, M

Velotti, F; Tubaro, A; Stoppacciaro, A; Pettinato, A; Morrone, S; Bossola, P; Napolitano, T; Miano, L; Ruco, L; Piccoli, M.

Affiliation

Velotti F; Dipartimento di Medicina Sperimentale, Università degli Studi La Sapienza, Rome, Italy.

Ann Ist Super Sanita ; 26(3-4): 411-21, 1990.

Article in En | MEDLINE | ID: mdl-2091503

Subject(s)

Carcinoma, Transitional Cell/therapy; Immunologic Factors/therapeutic use; Interleukin-2/therapeutic use; Urinary Bladder Neoplasms/therapy; Adult; Aged; Drug Evaluation; Humans; Immunologic Factors/administration & dosage; Infusions, Intra-Arterial; Interleukin-2/administration & dosage; Middle Aged; Neoplasm Recurrence, Local; Recombinant Proteins/administration & dosage; Recombinant Proteins/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Interleukin-2 / Immunologic Factors Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Ann Ist Super Sanita Year: 1990 Document type: Article Affiliation country: Italy Country of publication: Italy

Search on Google

Add to My VHL

XML

PubMed Links